Cantor Fitzgerald Europe lowers stake in SymBio Pharmaceuticals to 9.11%
Stake history
Summary
Cantor Fitzgerald Europe filed a Change in 5%+ stake (change report) via EDINET on 2025-02-28 13:57 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 9.11%, previous report: 10.22%.